Tag: Deviation

Identifying and Addressing Diversion Risk Signals in Controlled Drug Manufacturing In the pharmaceutical industry, particularly in controlled drug manufacturing, diversion risk signals can indicate significant regulatory compliance issues. This article…

Addressing Chain of Custody Breaches in Controlled Drug Manufacturing: A Comprehensive Investigation Guide Chain of custody breaches during controlled drug manufacturing are serious concerns that can compromise product integrity, regulatory…

Mitigating Regulatory Enforcement Risks from Diversion Signals during Warehousing In the pharmaceutical industry, the handling of controlled substances is a critical process that requires strict adherence to Good Manufacturing Practice…

Understanding and Addressing Inventory Reconciliation Mismatch in Controlled Drug Manufacturing Inventory reconciliation mismatch during controlled drug manufacturing presents significant challenges for pharmaceutical companies, typically manifesting as deviations, Out of Specification…

Diversion Risk Signals During Warehousing: Essential Documentation for Compliance The proper handling of controlled substances is critical for maintaining compliance in pharmaceutical manufacturing. When diversion risk signals arise during warehousing,…

Mitigating Regulatory Risks in Case of a Chain of Custody Breach During DEA/FDA Inspections In the highly regulated environment of pharmaceutical manufacturing, a chain of custody breach during a DEA…